0001659956-15-000001.txt : 20151204 0001659956-15-000001.hdr.sgml : 20151204 20151204145201 ACCESSION NUMBER: 0001659956-15-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20151204 DATE AS OF CHANGE: 20151204 EFFECTIVENESS DATE: 20151204 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Prosetta Biosciences Inc. CENTRAL INDEX KEY: 0001659956 IRS NUMBER: 464080003 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-252452 FILM NUMBER: 151269826 BUSINESS ADDRESS: STREET 1: 670 5TH ST. CITY: SAN FRANCISCO STATE: CA ZIP: 94107 BUSINESS PHONE: 415-346-8866 MAIL ADDRESS: STREET 1: 670 5TH ST. CITY: SAN FRANCISCO STATE: CA ZIP: 94107 D 1 primary_doc.xml X0707 D LIVE 0001659956 Prosetta Biosciences Inc. 670 5th Street SAN FRANCISCO CA CALIFORNIA 94107 415-346-8866 DELAWARE None None Corporation true 2013 Michael D. Farmer 670 5th Street SAN FRANCISCO CA CALIFORNIA 94107 Executive Officer Director Molly Coye 670 5th Street SAN FRANCISCO CA CALIFORNIA 94107 Director Thomas Higgins 670 5th Street SAN FRANCISCO CA CALIFORNIA 94107 Director David Keys 670 5th Street SAN FRANCISCO CA CALIFORNIA 94107 Director Vishwanath Lingappa 670 5th Street SAN FRANCISCO CA CALIFORNIA 94107 Executive Officer Director Karl Manheim 670 5th Street SAN FRANCISCO CA CALIFORNIA 94107 Director Joseph("Mike") McCune 670 5th Street SAN FRANCISCO CA CALIFORNIA 94107 Director Abel Weinrib 670 5th Street SAN FRANCISCO CA CALIFORNIA 94107 Director Phil Satow 670 5th Street SAN FRANCISCO CA CALIFORNIA 94107 Director CJ Sylvester 670 5th Street SAN FRANCISCO CA CALIFORNIA 94107 Director Biotechnology Decline to Disclose 06b false 2015-02-06 false true true false 6750 T.R. Winston & Company, LLC 10571 None None 2049 Century Park East, Suite 320 Los Angeles CA CALIFORNIA 90067 CA CALIFORNIA MA MASSACHUSETTS MI MICHIGAN NY NEW YORK OR OREGON PA PENNSYLVANIA WA WASHINGTON false 31096778 31096778 0 false 23 2114407 0 T.R.Winston will also receive warrants to purchase Series D Preferred Stock with an aggregate value equal to 3.0% of gross proceeds raised in the offering and reimbursement for legal expenses up to $50,000. 0 false Prosetta Biosciences Inc. /s/ Michael D. Farmer Michael D. Farmer President & Co-CEO 2015-12-03